AI English summary of an SEC filing — figures as filed
Ulta Beauty ULTAUlta Beauty said net sales for the 13 weeks ended August 3, 2024 rose $22.3 million (0.9%) to $2.6 billion, and comparable sales fell 1.2%. The company said transactions decreased 1.8% while average ticket increased 0.6%.
Key points
AI summaryUlta Beauty said net sales for the 13 weeks ended August 3, 2024 rose $22.3 million (0.9%) to $2.6 billion, and comparable sales fell 1.2%. The company said transactions decreased 1.8% while average ticket increased 0.6%.
The company said its gross profit margin for the 13 weeks fell to 38.3% from 39.3% a year earlier, and its SG&A ratio rose to 25.3% from 23.7%. Net income was $252.6 million, compared with $300.1 million a year earlier.
The company said it had cash and cash equivalents of $414.0 million as of August 3, 2024, compared with $766.6 million as of February 3, 2024 and $388.6 million as of July 29, 2023. Inventory stood at $2.0 billion, up $182.7 million (10.1%) from July 29, 2023.
The company said it had no outstanding borrowings under its credit facility as of August 3, 2024. The facility provides revolving loans of up to $800.0 million or a percentage of eligible owned inventory and eligible owned receivables, whichever is less. On March 2024, the Board of Directors authorized a 2024 Share Repurchase Program of up to $2.0 billion.
Key figures
Quarter ended August 3, 2024
- Revenue
- $2.6B
- Operating income
- $329M
- Net income
- $253M
- EPS
- $5.30
- Gross profit
- $978M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Ulta Beauty 13-week net sales of $2.6 billion, comparable sales down 1.2%
Ulta Beauty said net sales for the 13 weeks ended August 3, 2024 rose $22.3 million (0.9%) to $2.6 billion, and comparable sales fell 1.2%. The company said transactions decreased 1.8% while average ticket increased 0.6%.
Source · Based on the MD&A text of the filing
13-Week Gross Margin, SG&A Ratio and Net Income
The company said its gross profit margin for the 13 weeks fell to 38.3% from 39.3% a year earlier, and its SG&A ratio rose to 25.3% from 23.7%. Net income was $252.6 million, compared with $300.1 million a year earlier.
Source · Based on the MD&A text of the filing
Cash and Inventory Balances
The company said it had cash and cash equivalents of $414.0 million as of August 3, 2024, compared with $766.6 million as of February 3, 2024 and $388.6 million as of July 29, 2023. Inventory stood at $2.0 billion, up $182.7 million (10.1%) from July 29, 2023.
Source · Based on the MD&A text of the filing
No Credit Facility Borrowings; 2024 Buyback Authorized
The company said it had no outstanding borrowings under its credit facility as of August 3, 2024. The facility provides revolving loans of up to $800.0 million or a percentage of eligible owned inventory and eligible owned receivables, whichever is less. On March 2024, the Board of Directors authorized a 2024 Share Repurchase Program of up to $2.0 billion.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…